Galectin Therapeutics (NASDAQ:GALT) Given Neutral Rating at HC Wainwright
Galectin Therapeutics (NASDAQ:GALT – Get Free Report)‘s stock had its “neutral” rating reissued by equities research analysts at HC Wainwright in a research report issued to clients and investors on Wednesday,Benzinga reports. Separately, StockNews.com downgraded shares of Galectin Therapeutics from a “hold” rating to a “sell” rating in a report on Monday, December 30th. Check […]
Galectin Therapeutics (NASDAQ:GALT – Get Free Report)‘s stock had its “neutral” rating reissued by equities research analysts at HC Wainwright in a research report issued to clients and investors on Wednesday,Benzinga reports. Separately, StockNews.com downgraded shares of Galectin Therapeutics from a “hold” rating to a “sell” rating in a report on Monday, December 30th. Check […]
